A Study to Assess Effectiveness of Venclexta (Venetoclax) in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia in Routine Clinical Practice in Russian Federation

NCT03873857 · clinicaltrials.gov ↗

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Lymphocytic Leukemia (CLL)
Cancer

Interventions

DRUG: Venetoclax

Sponsor

AbbVie